Sunanda A. Ranadive

1.1k total citations
7 papers, 460 citations indexed

About

Sunanda A. Ranadive is a scholar working on Molecular Biology, Pharmaceutical Science and Oncology. According to data from OpenAlex, Sunanda A. Ranadive has authored 7 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Pharmaceutical Science and 2 papers in Oncology. Recurrent topics in Sunanda A. Ranadive's work include Crystallization and Solubility Studies (2 papers), Drug Solubulity and Delivery Systems (2 papers) and Computational Drug Discovery Methods (2 papers). Sunanda A. Ranadive is often cited by papers focused on Crystallization and Solubility Studies (2 papers), Drug Solubulity and Delivery Systems (2 papers) and Computational Drug Discovery Methods (2 papers). Sunanda A. Ranadive collaborates with scholars based in United States, Germany and Switzerland. Sunanda A. Ranadive's co-authors include Abu T.M. Serajuddin, Eileen M. Mahoney, Andrew Chen, Sailesh A. Varia, Kenneth R. Morris, M. Fakes, Ajit B. Thakur, Ann Newman, Ambarish K. Singh and Harry G. Brittain and has published in prestigious journals such as International Journal of Pharmaceutics, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Sunanda A. Ranadive

7 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sunanda A. Ranadive United States 6 143 111 91 83 73 7 460
Albert S. Kearney United States 10 146 1.0× 87 0.8× 48 0.5× 44 0.5× 74 1.0× 17 375
Chyung S. Cook United States 13 268 1.9× 200 1.8× 64 0.7× 65 0.8× 74 1.0× 29 850
Katsumi Iga Japan 13 120 0.8× 128 1.2× 27 0.3× 23 0.3× 37 0.5× 42 464
Atsuko Higashida United States 8 206 1.4× 139 1.3× 29 0.3× 47 0.6× 95 1.3× 12 557
Toshiya Moriwaki Japan 13 67 0.5× 77 0.7× 65 0.7× 20 0.2× 124 1.7× 26 500
Carsten Schmeck Germany 15 43 0.3× 309 2.8× 69 0.8× 21 0.3× 45 0.6× 26 759
Rebecca L. Oberle United States 7 196 1.4× 68 0.6× 44 0.5× 64 0.8× 21 0.3× 9 472
Masayuki Akimoto Japan 12 169 1.2× 129 1.2× 29 0.3× 25 0.3× 28 0.4× 39 490
Xavier Boulenc France 15 109 0.8× 198 1.8× 45 0.5× 37 0.4× 11 0.2× 19 814
Yasutaka Igari Japan 14 146 1.0× 152 1.4× 44 0.5× 25 0.3× 16 0.2× 19 603

Countries citing papers authored by Sunanda A. Ranadive

Since Specialization
Citations

This map shows the geographic impact of Sunanda A. Ranadive's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunanda A. Ranadive with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunanda A. Ranadive more than expected).

Fields of papers citing papers by Sunanda A. Ranadive

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunanda A. Ranadive. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunanda A. Ranadive. The network helps show where Sunanda A. Ranadive may publish in the future.

Co-authorship network of co-authors of Sunanda A. Ranadive

This figure shows the co-authorship network connecting the top 25 collaborators of Sunanda A. Ranadive. A scholar is included among the top collaborators of Sunanda A. Ranadive based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sunanda A. Ranadive. Sunanda A. Ranadive is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Serajuddin, Abu T.M., Ajit B. Thakur, M. Fakes, et al.. (1999). Selection of solid dosage form composition through drug–excipient compatibility testing. Journal of Pharmaceutical Sciences. 88(7). 696–704. 145 indexed citations
2.
Desai, Divyakant, et al.. (1996). Dissolution instability of encapsulated marketed tablets. International Journal of Pharmaceutics. 144(2). 153–158. 5 indexed citations
3.
Brittain, Harry G., Sunanda A. Ranadive, & Abu T.M. Serajuddin. (1995). Effect of Humidity-Dependent Changes in Crystal Structure on the Solid-State Fluorescence Properties of a New HMG-CoA Reductase Inhibitor. Pharmaceutical Research. 12(4). 556–559. 3 indexed citations
4.
Ranadive, Sunanda A., et al.. (1995). Formation, isolation and identification of oligomers of aztreonam. European Journal of Pharmaceutical Sciences. 3(5). 281–291. 6 indexed citations
5.
Morris, Kenneth R., Ann Newman, Sunanda A. Ranadive, et al.. (1994). Characterization of humidity-dependent changes in crystal properties of a new HMG-CoA reductase inhibitor in support of its dosage form development. International Journal of Pharmaceutics. 108(3). 195–206. 23 indexed citations
6.
Ranadive, Sunanda A., Andrew Chen, & Abu T.M. Serajuddin. (1992). Relative Lipophilicities and Structural-Pharmacological Considerations of Various Angiotensin-Converting Enzyme (ACE) Inhibitors. Pharmaceutical Research. 9(11). 1480–1486. 99 indexed citations
7.
Serajuddin, Abu T.M., Sunanda A. Ranadive, & Eileen M. Mahoney. (1991). Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and Simvastatin. Journal of Pharmaceutical Sciences. 80(9). 830–834. 179 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026